Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma Samples.

Corless BC, Chang GA, Cooper S, Syeda MM, Shao Y, Osman I, Karlin-Neumann G, Polsky D.

J Mol Diagn. 2019 Mar;21(2):274-285. doi: 10.1016/j.jmoldx.2018.09.003. Epub 2018 Oct 26.

2.

Mutational Heterogeneity in Melanoma: An Inconvenient Truth.

Chang GA, Polsky D.

J Invest Dermatol. 2015 Dec;135(12):2913-2918. doi: 10.1038/jid.2015.351.

3.

Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression.

Chang GA, Tadepalli JS, Shao Y, Zhang Y, Weiss S, Robinson E, Spittle C, Furtado M, Shelton DN, Karlin-Neumann G, Pavlick A, Osman I, Polsky D.

Mol Oncol. 2016 Jan;10(1):157-65. doi: 10.1016/j.molonc.2015.09.005. Epub 2015 Sep 25.

4.

Inter-rater reliability of the Mallampati classification for patients in a dental hygiene clinic.

Kandray DP, Juruaz D, Yacovone M, Chang GA.

J Dent Hyg. 2013 Jun;87(3):134-9.

PMID:
23986329
5.

Coordinating the impact of structural genomics on the human α-helical transmembrane proteome.

Pieper U, Schlessinger A, Kloppmann E, Chang GA, Chou JJ, Dumont ME, Fox BG, Fromme P, Hendrickson WA, Malkowski MG, Rees DC, Stokes DL, Stowell MH, Wiener MC, Rost B, Stroud RM, Stevens RC, Sali A.

Nat Struct Mol Biol. 2013 Feb;20(2):135-8. doi: 10.1038/nsmb.2508. No abstract available.

6.

Influence of credentials of clinical laboratory professionals on proficiency testing performance.

Delost MD, Miller WG, Chang GA, Korzun WJ, Nadder TS.

Am J Clin Pathol. 2009 Oct;132(4):550-4. doi: 10.1309/AJCPWCBSYISV1ASI.

PMID:
19762532
7.

Age of inhalant first time use and its association to the use of other drugs.

Ding K, Chang GA, Southerland R.

J Drug Educ. 2009;39(3):261-72.

PMID:
20196331

Supplemental Content

Loading ...
Support Center